Author: Bill Snyder
Hawiger still blazing a trail in inflammation research
Nov. 10, 2022—Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.
Study defines role of steroids in congenital heart disease surgery
Nov. 10, 2022—Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
Event to spotlight VUMC’s COVID-19 research efforts
Nov. 3, 2022—The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.
VUMC mourns loss of noted hypertension expert Elijovich
Oct. 28, 2022—Fernando Elijovich, MD, professor of Medicine in the Division of Clinical Pharmacology at Vanderbilt University Medical Center, died in Nashville on Oct. 21. He was 77.
Translational Research Forum highlights range of studies
Oct. 27, 2022—The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that are translating scientific discovery into clinical practice.
Nominations for Vanderbilt Prize now being accepted
Oct. 27, 2022—Nominations for the 2023 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 1.
Aging beta cells hasten Type 2 diabetes
Oct. 20, 2022—Vanderbilt investigators have found that aging induces chronic cellular stress in pancreatic beta cells, which could contribute to the development of diabetes as we age.
Gaudet set to deliver Elam Memorial Lecture Oct. 26
Oct. 13, 2022—Patient-centered health care expert Tracy Gaudet, MD, will deliver the third annual Dr. Roy O. Elam Memorial Lecture Oct. 26 at noon in 214 Light Hall.
Counting steps can reduce disease risk: study
Oct. 10, 2022—A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases.
Opening a window to glaucoma
Oct. 10, 2022—A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.
Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Oct. 6, 2022—Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.